Novel TACE inhibitors in drug discovery: a review of patented compounds

Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-α converting enzyme (TACE) inhibitors

(2009) Kaapjoo Park et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Studies on novel 2-imidazolidinones and tetrahydropyrimidin-2(1H)-ones as potential TACE inhibitors: Design, synthesis, molecular modeling, and preliminary biological evaluation

(2009) Shirshendu DasGupta et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Current perspective of TACE inhibitors: A review

(2008) Shirshendu DasGupta et al.   BIOORGANIC & MEDICINAL CHEMISTRY

α,β-Cyclic-β-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-α converting enzyme (TACE)

(2008) Gregory R. Ott et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

3D-Quantitative Structure–Activity Relationship Studies on Benzothiadiazepine Hydroxamates as Inhibitors of Tumor Necrosis Factor-α Converting Enzyme

(2008) Prashant R. Murumkar et al.   Chemical Biology & Drug Design

Development of Predictive 3D-QSAR CoMFA and CoMSIA Models for β-aminohydroxamic Acid-Derived Tumor Necrosis Factor-α Converting Enzyme Inhibitors

(2008) Prashant R. Murumkar et al.   Chemical Biology & Drug Design

Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis

(2008) Marcia L Moss et al.   Nature clinical practice. Rheumatology